InvestorsHub Logo
Followers 68
Posts 7758
Boards Moderated 0
Alias Born 03/06/2016

Re: bas2020 post# 185984

Thursday, 03/21/2019 9:51:31 AM

Thursday, March 21, 2019 9:51:31 AM

Post# of 474408
I guess Biogen is not looking at us. If they were going to make an acquisition one would think they would do it while their share price was higher. They had to know that backing out of aducanumab would drop their share price significantly. Analyst had pegged appx 25% of their revenue from their Alzheimer’s drug. It look like we are the only game in town and hopefully draw attention to us. We should be approaching $20/sh before we hear any of readouts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News